BDSX - CIK 0001439725
BIODESIX INC (BDSX) reported revenue of $88.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $88.50M | +24.1% |
| FY 2024 | $71.32M | +45.3% |
| FY 2023 | $49.09M | +28.5% |
| FY 2022 | $38.21M | -29.9% |
| FY 2021 | $54.51M | +19.6% |
| FY 2020 | $45.56M | +85.6% |
| FY 2019 | $24.55M | - |
BIODESIX INC (BDSX) reported revenue of $88.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, BIODESIX INC's revenue grew from $24.55M to $88.50M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.